G20 Global Pharma Summit Series-Indonesia

The shift to curative treatments has the potential to change the entire healthcare system. Patients whose diseases were previously controlled with long-term medicine can now be cured with particular treatments. This changes their lives, but as this essay illustrates, it also has a disruptive influence on the broader market, moving payer expenditure, emphasising the importance of first-mover advantage for pharmaceutical companies, and altering care models for healthcare providers.